microdosing glp 1 menopause GLP-1 During Menopause: Is it Right for You? Why I'm Microdosing a GLP-1

GLP-1 +3 Mar 19, 2026 7 min read A shift in what's possible for diabetes and obesity GLP-1 +5 Dec 16, 2025 40 min read Incretins are changing the narrative of chronic kidney disease GLP-1 +3 Dec 11, 2025 10 min read Bariatric surgery in a shot

And most importantly, does it actually work or is this another overhyped supplement promising results it cannot deliver

This article will provide a comprehensive guide from a pharmacist to anyone on a GLP-1 medication or thinking about starting one

Start by reviewing your insurers policy to understand their requirements

liraglutide significantly decreased body fat and waist-to-hip ratio (p=0.003), and exenatide reduced waist-to-hip ratio but had minimal weight loss benefits.[6] In the STEP1 study, adults with obesity without diabetes receiving semaglutide 2.4mg plus lifestyle interventions had a mean weight loss of 14.9% from baseline in addition to improved fasting glucose and lipids, increased physical activity, and decreased fat mass.[7] The SURMOUNT-1 trial demonstrated that tirzepatide 5mg, 10mg, and 15mg caused significant improvement in weight, total body fat mass, lipids, systolic and diastolic blood pressure, and fasting insulin levels.[5] Cardiovascular disease risk reduction Diabetes represents a major risk factor for cardiovascular disease

Protein provides the essential amino acids needed to repair microscopic tears caused by exercise and build new muscle tissue